Urinary biomarker
Showing 1 - 25 of 9,286
Urinary Biomarker in Membranous Glomerulonephritis
Not yet recruiting
- Membranous Nephropathy
- urinary markers
- (no location specified)
Jan 18, 2023
Acute Kidney Injury Trial in Singapore (AKI risk screening using RenaFAST POCT test kits)
Recruiting
- Acute Kidney Injury
- AKI risk screening using RenaFAST POCT test kits
-
Singapore, SingaporeNational University Hospital
Nov 6, 2023
Diagnostic Tool for AKI in Sepsis
Completed
- Sepsis at Intensive Care Unit
- Urinary proteomic analysis
-
Ghent, BelgiumGhent University Hospital
Dec 9, 2022
Early Detection of Cardiac Surgery-associated Pediatric Acute
Recruiting
- Acute Kidney Injury
- Discarded urine sample
-
Boston, MassachusettsBoston Children's Hospital
Jan 31, 2022
ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED
Completed
- Renal Failure
- Biomarkers
-
Hyderabad, Telangana, IndiaAsian Institute of Gastroenterology
Dec 23, 2021
Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney
Recruiting
- Acute Kidney Injury
- Nephrocheck (AKI score)
-
Milan, ItalyFondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Jun 19, 2023
Urinary Uromodulin and Corresponding Urinary Exosomal UMOD mRNA
Completed
- Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression
- ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
-
Tanta, Al Gharbia, EgyptTanta university hospital, faculty of science, tanta university
Jan 24, 2023
Personalized Urine Biomarker for Patients With Bladder Cancer
Not yet recruiting
- Bladder Neoplasm
- TURBT
- (no location specified)
Jul 17, 2022
Urinary Biomarkers of OI Pathobiology
Active, not recruiting
- Osteogenesis Imperfecta
-
Los Angeles, California
- +6 more
Feb 24, 2022
Urine-DNA Biomarkers in Detecting Bladder Cancer
Completed
- Bladder Cancer
- +3 more
- Next generation sequencing
-
Changsha, Hunan, ChinaXiangya Hospital of Central South Univeristy
Nov 7, 2022
Urinary T Cell Biomarker for Prediction in Lupus Nephritis
Active, not recruiting
- Lupus Nephritis
- Flow cytometry analysis of urine samples
-
Berlin, Germany
- +1 more
Mar 8, 2022
Bladder Cancer Trial in Xi'an (analysis of urine volatile organic compounds)
Recruiting
- Bladder Cancer
- analysis of urine volatile organic compounds
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Jan 10, 2023
Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)
Recruiting
- Renal Transplantation
- +2 more
- Biomarker test
-
Tuebingen, GermanyUniversity Children's Hospital Tuebingen
Jan 11, 2022
Overactive Bladder Syndrome, Detrusor Overactivity Trial (Mirabegron 50 MG, Solifenacin Succinate 5 MG)
Not yet recruiting
- Overactive Bladder Syndrome
- Detrusor Overactivity
- Mirabegron 50 MG
- Solifenacin Succinate 5 MG
- (no location specified)
Jan 25, 2021
Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)
Withdrawn
- Bladder Transitional Cell Carcinoma
- +2 more
- (no location specified)
Aug 8, 2022
Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,
Active, not recruiting
- Bladder Urothelial Carcinoma
- +4 more
- Biopsy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
Recruiting
- Bladder Cancer
- +12 more
-
Raleigh, North CarolinaxCures Virtual Site
Sep 20, 2021
Urine Biomarker for Stone Recurrence
Recruiting
- Urolithiasis
-
Shatin, Hong KongPrince of Wales Hospital
Aug 3, 2021
Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG
Active, not recruiting
- Recurrent Bladder Carcinoma
- +3 more
- BCG Solution
- +3 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2022
Biomarker Identification for Bladder Cancer Patients
Active, not recruiting
- Bladder Cancer
- Sample Collection
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Mar 11, 2021
Transitional Cell Carcinoma of the Bladder, Biomarkers Trial in Rotterdam (Pembrolizumab)
Active, not recruiting
- Transitional Cell Carcinoma of the Bladder
- Biomarkers
-
Rotterdam, NetherlandsErasmus MC
Aug 19, 2021
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021